miR-125b predicts childhood acute lymphoblastic leukaemia poor response to BFM chemotherapy treatment

BACKGROUND: Despite the favourable survival rates of childhood acute lymphoblastic leukaemia (ALL), a significant number of patients present resistance to antileukaemic agents and dismal prognosis. In this study, we analysed miR-125b expression in childhood ALL and evaluated its clinical utility for...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Br J Cancer
Main Authors: Piatopoulou, Despina, Avgeris, Margaritis, Marmarinos, Antonios, Xagorari, Marieta, Baka, Margarita, Doganis, Dimitrios, Kossiva, Lydia, Scorilas, Andreas, Gourgiotis, Dimitrios
Formato: Artigo
Idioma:Inglês
Publicado em: Nature Publishing Group 2017
Assuntos:
Translational Therapeutics
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC5589998/
https://ncbi.nlm.nih.gov/pubmed/28787435
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/bjc.2017.256
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados